Edwards Lifesciences Corp Stock Market Value
| EW Stock | USD 71.27 0.79 1.12% |
| Symbol | Edwards |
Edwards Lifesciences Corp Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 7.161 | Earnings Share 2.62 | Revenue Per Share 10.498 | Quarterly Revenue Growth 0.089 | Return On Assets 0.1065 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Edwards Lifesciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Edwards Lifesciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Edwards Lifesciences.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in Edwards Lifesciences on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding Edwards Lifesciences Corp or generate 0.0% return on investment in Edwards Lifesciences over 510 days. Edwards Lifesciences is related to or competes with Medtronic PLC, Abbott Laboratories, Boston Scientific, Zimmer Biomet, Stryker, DexCom, and Insulet. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and ... More
Edwards Lifesciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Edwards Lifesciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Edwards Lifesciences Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.58 | |||
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 8.56 | |||
| Value At Risk | (2.36) | |||
| Potential Upside | 2.42 |
Edwards Lifesciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Edwards Lifesciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Edwards Lifesciences' standard deviation. In reality, there are many statistical measures that can use Edwards Lifesciences historical prices to predict the future Edwards Lifesciences' volatility.| Risk Adjusted Performance | 0.0153 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | (0.07) | |||
| Treynor Ratio | 0.05 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edwards Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edwards Lifesciences Corp Backtested Returns
At this stage we consider Edwards Stock to be very steady. Edwards Lifesciences Corp secures Sharpe Ratio (or Efficiency) of 0.0449, which denotes the company had a 0.0449% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Edwards Lifesciences Corp, which you can use to evaluate the volatility of the firm. Please confirm Edwards Lifesciences' Coefficient Of Variation of 7646.98, downside deviation of 1.58, and Mean Deviation of 1.22 to check if the risk estimate we provide is consistent with the expected return of 0.072%. Edwards Lifesciences has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.23, which means not very significant fluctuations relative to the market. As returns on the market increase, Edwards Lifesciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Edwards Lifesciences is expected to be smaller as well. Edwards Lifesciences Corp right now shows a risk of 1.6%. Please confirm Edwards Lifesciences Corp potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Edwards Lifesciences Corp will be following its price patterns.
Auto-correlation | 0.08 |
Virtually no predictability
Edwards Lifesciences Corp has virtually no predictability. Overlapping area represents the amount of predictability between Edwards Lifesciences time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Edwards Lifesciences Corp price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Edwards Lifesciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 130.12 |
Edwards Lifesciences Corp lagged returns against current returns
Autocorrelation, which is Edwards Lifesciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Edwards Lifesciences' stock expected returns. We can calculate the autocorrelation of Edwards Lifesciences returns to help us make a trade decision. For example, suppose you find that Edwards Lifesciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Edwards Lifesciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Edwards Lifesciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Edwards Lifesciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Edwards Lifesciences stock over time.
Current vs Lagged Prices |
| Timeline |
Edwards Lifesciences Lagged Returns
When evaluating Edwards Lifesciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Edwards Lifesciences stock have on its future price. Edwards Lifesciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Edwards Lifesciences autocorrelation shows the relationship between Edwards Lifesciences stock current value and its past values and can show if there is a momentum factor associated with investing in Edwards Lifesciences Corp.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.